Table 3

Clinical studies evaluating deformation parameters during DSE for the assessment of viability

AuthorNo. of patientsMethod of deformation analysisPatient characteristicsDefinition of viabilityParametersViability±scar response*Predictive value†
Hoffmann et al1737TDIPrevious myocardial infarction with reduced LVEF (mean LVEF 44±10%)DSE: Improvement by ≥ 1 grade in WMS in segments abnormal at rest
PET-18FDG: Tetrofosmin uptake ≤70% +a better preserved 18FDG uptake (18FDG—tetrofosmin uptake >20%)
PSSRViability: ↑ PSSR vs unchanged PSSR for non-viable segmentsAUC for PSSR for prediction of scar was 0.89 (95% CI 0.88 to 0.90)
Sensitivity and specificity of PSSR 83%+84% respectively vs 75% and 63% for WMS
Hanekom et al1555TDIPrevious myocardial infarction; mean LVEF 36±8%Regional (WMS) and global (≥5% ↑in LVEF) recovery in LV function on TTE 9 months post-revascularisationSR, ΔSR, SS (end-systolic), ΔSS, PSS, PSI, ΔPSI, timing parametersScar:  ↓SR, ↓ΔSR, ↓SS, ↓ΔSS, ↑timing parametersSensitivity and specificity of TDI magnitude parameters (highest 80% for ΔSR) better than WMS (73%) but similar specificity (77%); WMS+TDI (low dose SR+ΔSR) sensitivity 82% and specificity 80%; AUC 0.88
Fujimoto et al1848TDIPrevious myocardial infarction with ‘decrease in contractile myocardium but no necrosis’ in the territory supplied by the culprit artery
Group 1 (n=38): DSE+coronary angiography
Group 2 (n=10) DSE before+after PCI
DSE: Uniphasic (sustained improvement in WMS at peak stress) or biphasic (improvement at low dose followed by dis-improvement at peak dose) response
Group 2 patients: Improvement in resting WMS by ≥1 grade in ≥2 segments
Total strain (TS), PSS, PSI, L/TS ratio (ratio of systolic lengthening to the sum of end- and post-systolic shortening)Viability: Peak stress PSI ≥0.25 in 80% of viable segments
Peak stress L/TS ratio >0 in 57% of viable segments
AUC of L/TS ratio to predict functional recovery was 0.89 vs 0.78 for WMS, p<0.05
L/TS ratio 84% sensitivity and 79% specificity vs 86% sensitivity and 71% specificity for WMS
Bansal et al1655TDI
STE
Known CAD+LVEF <45%Improvement in resting wall motion (per segment) on TTE 9 months post-revascularisationTDI: PSSR and SS (end-systolic)
STE: longitudinal, circumferential and radial strain and strain rate (LSS/LSR, CSS/CSR, RS/RSR)
Viability: STE: ↑ strain in all 3 directions and ↑LSR+CSR at rest; ↑LSS and CSS/CSR at low dose
TDI:↑PSSR+SS at rest and low dose
PSSR+SS at low dose and CSS at rest and low dose only independent predictors of LV functional recovery
PSSR+SS showed incremental value over WMS (AUC 0.79, 0.79 and 0.74, respectively).
Rosner et al1972TDIN=57 patients scheduled for CABG (normal and moderately reduced LVEF; mean 49%)+undergoing pre-op MRI
N=15 healthy controls
TTE: Difference in ET strain ≥4.4% between pre- and 8–10 months post-CABG resting TTE
MRI: LGE <50%
SS (peak/ET), mean SSR, PSS, PSI, ΔSS, ΔSRViability: ΔSS significantly identified both hypokinetic and akinetic segments improving after CABG
Peak SS+SR, PSS, ΔSR significantly identified akinetic segments improving after CABG
Sum of pre-op DSE SS increment and resting SS (had the highest correlation coefficient for strain defined viability (R=0.61, p<0.001))
AUC for DSE SS increment was 0.79
  • *Indicates response of parameters at low dose stress unless indicated.

  • †Indicates predictive value of peak dose stress parameters unless indicated.

  • AUC, area under the curve; CABG, coronary artery bypass grafting; CAD, coronary artery disease; DSE, dobutamine stress echocardiography; ET, ejection time; LGE, late gadolinium enhancement; PCI, percutaneous coronary intervention; PET-18FDG, positron emission tomography using 18F-flurodeoxyglucose; PSI, post-systolic shortening index; PSS, post-systolic strain; PSSR, peak systolic strain rate; SPECT, single photon emission CT; SR, strain rate; SS, systolic strain; STE, speckle tracking echocardiography; TDI, tissue Doppler imaging; TTE, transthoracic echocardiography; WMS, wall motion scoring; WMSI; wall motion score index.